Vifor Pharma AG banner
V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48%
Market Cap: CHf10.8B

Wall Street
Price Targets

VIFN Price Targets Summary
Vifor Pharma AG

There are no price targets for VIFN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Vifor Pharma AG Competitors:
Price Targets
CPNREIT
CPN Retail Growth Leasehold REIT
7% Upside

Revenue
Forecast

-8% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
-8% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 8 years the compound annual growth rate for Vifor Pharma AG's revenue is -8%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

-1% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
-1% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 8 years the compound annual growth rate for Vifor Pharma AG's operating income is -1%. The projected CAGR for the next 3 years is 16%.

Net Income
Forecast

-9% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
-9% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 8 years the compound annual growth rate for Vifor Pharma AG's net income is -9%. The projected CAGR for the next 3 years is 31%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VIFN's stock price target?
Not Available

VIFN doesn't have any price targets made by Wall Street professionals.

What is Vifor Pharma AG's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Vifor Pharma AG's revenue is -8%. The projected CAGR for the next 3 years is 11%.

What is Vifor Pharma AG's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Vifor Pharma AG's operating income is -1%. The projected CAGR for the next 3 years is 16%.

What is Vifor Pharma AG's Net Income forecast?
Projected CAGR
31%

For the last 8 years the compound annual growth rate for Vifor Pharma AG's net income is -9%. The projected CAGR for the next 3 years is 31%.

Back to Top